Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Edwards Lifesciences
(NY:
EW
)
84.65
+1.19 (+1.43%)
Streaming Delayed Price
Updated: 12:54 PM EST, Jan 21, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Edwards Lifesciences
< Previous
1
2
3
4
5
6
7
8
9
...
21
22
Next >
Edwards SAPIEN 3 TAVR Delivers Proven Long-term Benefits and Valve Performance, New Data Presented at TCT 2025
October 27, 2025
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences to Host Earnings Conference Call on October 30, 2025
October 23, 2025
From
Edwards Lifesciences Corporation
Via
Business Wire
EW Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW
October 16, 2025
From
The Rosen Law Firm, P.A.
Via
Business Wire
Nvidia, Citi, AT&T, Lucid, Edwards Sciences: What Sparked Heavy After-Hours Trading In These 5 Stocks?
↗
August 22, 2025
Via
Stocktwits
EW Investor News: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW
October 15, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
EW Investor News: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW
October 11, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
Here's How Much $100 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth Today
↗
October 10, 2025
Via
Benzinga
Wealth Manager Doubles Down on Adobe, According to Recent SEC Filing
↗
October 09, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
Wealth Manager Takes Big New Stake in Visa, According to Latest Filing
↗
October 09, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
EW Investor News: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW
October 08, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
Which S&P500 stocks are gapping on Wednesday?
↗
October 08, 2025
Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Wednesday to uncover the stocks that are gapping in the S&P500 index.
Via
Chartmill
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 20 Years
↗
September 29, 2025
Edwards Lifesciences (NYSE: EW) has outperformed the market over the past 20 years by 7.57% on an annualized basis producing an average annual return of 16.53%. Currently, Edwards Lifesciences has a...
Via
Benzinga
EW Investor News: If You Have Suffered Losses in Edwards Lifesciences Corporation (NYSE: EW), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
September 26, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
EW Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW
September 24, 2025
From
Rosen Law Firm
Via
Business Wire
Analyst Expectations For Edwards Lifesciences's Future
↗
September 22, 2025
Via
Benzinga
EDWARDS (EW) ALERT: Bragar Eagel & Squire, P.C. is Investigating Edwards Lifesciences Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
September 16, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Here Are Billionaire Ken Griffin's 5 Biggest Stock Holdings
↗
September 09, 2025
One was recently acquired by a much bigger company.
Via
The Motley Fool
Topics
Artificial Intelligence
Energy
3 Healthcare Pathbreakers With Long-Term Tailwinds
↗
September 01, 2025
These three firms in the fast-changing healthcare sector stand out to analysts for their strong product lineups, defensible technology, and notable pipelines.
Via
MarketBeat
Updated ESC/EACTS Guidelines Mark Advancement in Structural Heart Disease Care
August 29, 2025
From
Edwards Lifesciences Corporation
Via
Business Wire
Israel Englander's Millennium Goes All-In On Crypto And Healthcare While Rebalancing Big Tech Bets: Bitcoin ETF And Palantir Stakes Soar In Q2
↗
August 27, 2025
Millennium Management's Q2 2025 13F reveals big bets on crypto (IBIT, PLTR) & healthcare (EW, INSM), with tech rebalancing. Read key changes!
Via
Benzinga
Topics
ETFs
Here's How Much $100 Invested In Edwards Lifesciences 20 Years Ago Would Be Worth Today
↗
August 26, 2025
Via
Benzinga
If You Invested $1000 In This Stock 15 Years Ago, You Would Have This Much Today
↗
August 20, 2025
Via
Benzinga
Edwards Lifesciences Announces $500 Million Accelerated Share Repurchase
August 19, 2025
From
Edwards Lifesciences Corporation
Via
Business Wire
EDWARDS (EW) ALERT: Bragar Eagel & Squire, P.C. is Investigating Edwards Lifesciences Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
August 13, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Here Are Billionaire Ken Griffin's 5 Biggest Stock Holdings
↗
August 11, 2025
A longtime leader in financial services tops the list.
Via
The Motley Fool
Deal Dispatch: Performance Food Group And Claire's Lead A Week Of Big Auctions, Retail Woes
↗
August 08, 2025
Performance Food rejects offer; Lufthansa drops Air Europa bid; NFL inks deal with ESPN; Claire's files bankruptcy amid retail struggles.
Via
Benzinga
Topics
Bankruptcy
FTC Sounds Alarm On Edwards' Attempt To Corner Heart Device Market
↗
August 08, 2025
The FTC complaint alleges that if Edwards acquires JenaValve, it would gain control over the two most advanced TAVR-AR devices.
Via
Benzinga
Edwards Lifesciences Comments on FTC’s Action to Block Proposed Acquisition of JenaValve
August 06, 2025
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences Stock: Likely To See Sluggish Price Action Through 2027
↗
August 06, 2025
Edwards Lifesciences may avoid bearishness but is likely to trade sluggishly through 2027, as key cycle phases signal limited upside potential.
Via
Benzinga
Edwards Lifesciences (EW) Q2 2025 Earnings Call Transcript
↗
August 05, 2025
Via
The Motley Fool
Topics
Earnings
< Previous
1
2
3
4
5
6
7
8
9
...
21
22
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
